Israeli approves compassionate use of MDMA to treat PTSD patients

The popular party drug, MDMA, also known as ecstasy, has officially been approved in Israel as a treatment for Post-traumatic stress disorder.

An Israeli government representative learned about the benefits of using MDMA to treat PTSD from the Multidisciplinary Association for Psychedelic Studies (MAPS), a California-based organization. Following their research, Israel has approved using MDMA to treat 50 patients suffering from PTSD.

“The ministry is taking this seriously and with appropriate caution, an in-depth investigation has been carried out,” Ministry of Health official Bella Ben-Gershon told sources. “There is a considerable population in Israel of people suffering from PTSD that is resistant to other treatment.”


Israeli study shows cannabis may relieve autism symptoms

The scientific community has struggled to gain a solid understanding of children suffering from autism. Since this condition affects every child differently, no blanket treatment option has yet been developed to give doctors are starting point when dealing with these type of patients. There is anecdotal evidence suggesting that cannabis might be part of the solution—similar to how it is for epilepsy—yet American researchers have been hindered from digging deeper into the possible benefits.​

But all is not lost. Scientists in Israel appear to have uncovered definitive proof that medical marijuana can help autistic kids deal with the worst of their symptoms and live a better quality of life.


Yes, medical cannabis works. So why deny the anecdotal evidence?

One of the most common arguments against the efficacy of medical cannabis today is that public policy is outpacing real science. Currently, 33 states along with the District of Columbia, Guam and Puerto Rico have passed laws for comprehensive medical cannabis programs -- but critics often point out we’re lacking definitive proof that marijuana safely and effectively treats many of the qualifying conditions.


Israel becomes third country to allow exports of medical marijuana

Israel has given final approval to a law permitting the export of medical marijuana, a move the government expects will catapult investment in local industry and agriculture.

The Cabinet’s decision Sunday came a month after the Israeli parliament unanimously approved the decision, making Israel the third country in the world, after the Netherlands and Canada, to allow export of medical cannabis products.

Israel is home to dozens of companies active in the medical marijuana industry, and approved companies will be able to export to countries where it is legal.


Israel's grass to grow greener, cabinet about to approve cannabis exports

High times are awaiting Israel’s cannabis and tech sectors, as the cabinet is set to approve legislation allowing the export of medical cannabis.

The bill passed its third reading in the Knesset last month and is pending only the cabinet’s and Prime Minister Benjamin Netanyahu’s confirmation to be signed into law, which is expected to happen on Sunday.

Israel is already considered a world leader in cannabis production, and the legalization of exports will boost the sector even more, allowing Israel to compete in an industry that is expected to reach $33 billion worldwide in the next five years. Tax revenue could rise as much as NIS 1b. through the export permit.


New Israeli-US investment fund for cannabis technology

A $30 million cannabis technology venture capital fund is under establishment by Jerusalem-based global investment platform OurCrowd and the 7thirty Opportunity Fund of Boulder, Colorad

The new fund will invest in emerging companies involved in med-tech, ag-tech, retail, e-commerce, marketplaces, SaaS solutions, and deep-tech research related to cannabis. It will be headquartered in Boulder with activities in Israel, Canada and the United States.


Distribution agreement struck between The Greater Cannabis Company and iCAN: Israel Cannabis Ltd.

The Greater Cannabis Company, Inc. (GCAN) has entered into a letter of intent (LOI) with iCAN Cannabis to expand distribution of GCAN’s eluting patch platform into key global markets.

The LOI calls for including commercial-ready formulations to meet medical and recreational market demands, notes a statement from iCAN: Israel Cannabis, an Israeli developer of cannabis-based formulations, clinical trials and cannabis testing.

“Distribution and marketing rights for iCAN will include Israel, Australia, South Africa, Netherlands, South Africa, Mexico, Colombia, Panama, Germany, Austria, Switzerland, Malta, Macedonia and Portuguese territories,” the statement adds.


Israel's pro-cannabis party plans to sue Facebook over blocked political ads

Israel's pro-cannabis party Green Leaf (Ale Yarok) are threatening Facebook with a lawsuit after the social media giant took down one of their publicity campaigns, writes Calvin Hughes. 


Israeli legislation paves the way for exporting medical cannabis in 2019

A bill revolving around the governance and regulatory aspects of exporting medical cannabis from Israel passed the Israeli Parliament on Christmas day, a move Seedo Corp. says brings the industry one step closer to finalizing export of medical cannabis.


Israel likely to allow medical cannabis exports

Israel will likely allow exports of medical cannabis by the end of the year, a top lawmaker said on Thursday, a move that would boost state coffers and slow the growing number of firms establishing farms abroad.

Israeli companies - befitting from a favourable climate and expertise in medical and agricultural technologies - are among the world's biggest producers of medical cannabis.

The finance and health ministries estimate exports could bring in about $1 billion a year - but some MPs have up to now stopped Israeli-grown cannabis going abroad, fearing more cultivation could push more drugs onto the streets at home.


Subscribe to RSS - Israel